Multivariate analysis confirms expression of APRIL protein in the tumour stroma as an independent prognostic factor in chemotherapy treated Stage III patients, with a HR of 6.25 (95% CI 1.48-26.32, p = 0.013, table 4). The gene discussed is TNFSF13; the disease is neoplasm.